259 related articles for article (PubMed ID: 34590156)
1. Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9.
Sheng W; Xu W; Ding J; Li L; You X; Wu Y; He Q
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34590156
[TBL] [Abstract][Full Text] [Related]
2. PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway.
Zhang X; Zhong S
Anticancer Agents Med Chem; 2020; 20(7):828-833. PubMed ID: 32188393
[TBL] [Abstract][Full Text] [Related]
3. microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.
Chen GM; Zheng AJ; Cai J; Han P; Ji HB; Wang LL
J Cell Biochem; 2018 Jan; 119(1):885-895. PubMed ID: 28661070
[TBL] [Abstract][Full Text] [Related]
4. miR-138 Reduces the Dysfunction of T Follicular Helper Cells in Osteosarcoma via the PI3K/Akt/mTOR Pathway by Targeting PDK1.
Jiang B; Kang X; Zhao G; Lu J; Wang Z
Comput Math Methods Med; 2021; 2021():2895893. PubMed ID: 34950224
[TBL] [Abstract][Full Text] [Related]
5. MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met.
Gao S; Zhao Z; Wu R; Wu L; Tian X; Zhang Z
Biomed Pharmacother; 2019 Jan; 109():1406-1410. PubMed ID: 30551391
[TBL] [Abstract][Full Text] [Related]
6. Biological impact and therapeutic potential of a novel camptothecin derivative (FLQY2) in pancreatic cancer through inactivation of the PDK1/AKT/mTOR pathway.
Wang W; Xiong H; Li L; Hu X; Zhuang W; Li J; Sun X; Yu Y; Yu Y; Guo Y; Wang Y; Wang R; Wang H; Li Q
Bioorg Chem; 2024 Jul; 148():107436. PubMed ID: 38735265
[TBL] [Abstract][Full Text] [Related]
7. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
Xu S; Ge J; Zhang Z; Zhou W
Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829
[TBL] [Abstract][Full Text] [Related]
8. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F
J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
[TBL] [Abstract][Full Text] [Related]
9. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
[TBL] [Abstract][Full Text] [Related]
10. Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways.
Liu H; Wang J; Tao Y; Li X; Qin J; Bai Z; Chi B; Yan W; Chen X
Life Sci; 2019 Mar; 221():354-361. PubMed ID: 30811964
[TBL] [Abstract][Full Text] [Related]
11. MiR-1271 negatively regulates AKT/MTOR signaling and promotes apoptosis via targeting PDK1 in pancreatic cancer.
Xie F; Huang Q; Liu CH; Lin XS; Liu Z; Liu LL; Huang DW; Zhou HC
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):678-686. PubMed ID: 29461595
[TBL] [Abstract][Full Text] [Related]
12. MiR-28 inhibits cardiomyocyte survival through suppressing PDK1/Akt/mTOR signaling.
Zhu RY; Zhang D; Zou HD; Zuo XS; Zhou QS; Huang H
In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):1020-1025. PubMed ID: 27338735
[TBL] [Abstract][Full Text] [Related]
13. Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7/m-TOR/SREBP1 pathway on prostate cancer.
Xu W; Ding J; Li B; Sun T; You X; He Q; Sheng W
Biofactors; 2023 Mar; 49(2):438-456. PubMed ID: 36585763
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
15. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
[TBL] [Abstract][Full Text] [Related]
16. Citrate activates autophagic death of prostate cancer cells via downregulation CaMKII/AKT/mTOR pathway.
Fan X; Zhou J; Yan X; Bi X; Liang J; Lu S; Luo L; Zhou D; Yin Z
Life Sci; 2021 Jun; 275():119355. PubMed ID: 33744326
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling.
Li JZ; Wang ZL; Xu WH; Li Q; Gao L; Wang ZM
Cancer Invest; 2016; 34(4):181-8. PubMed ID: 27031291
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑126‑3p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway.
Ichikawa R; Kawasaki R; Iwata A; Otani S; Nishio E; Nomura H; Fujii T
Oncol Rep; 2020 Apr; 43(4):1300-1308. PubMed ID: 32323808
[TBL] [Abstract][Full Text] [Related]
19. PDK1 Mediates
Sambandam V; Frederick MJ; Shen L; Tong P; Rao X; Peng S; Singh R; Mazumdar T; Huang C; Li Q; Pickering CR; Myers JN; Wang J; Johnson FM
Clin Cancer Res; 2019 Jun; 25(11):3329-3340. PubMed ID: 30770351
[TBL] [Abstract][Full Text] [Related]
20. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
